Peanut Allergies Not Yet Recruiting Phase 2 Trials for Omalizumab (DB00043)

Also known as: Peanut Allergy / Allergy to peanuts / Peanut Hypersensitivity / Food allergy / Food Hypersensitivity

IndicationStatusPhase
DBCOND0071500 (Peanut Allergies)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03679676Clinical Study Using Biologics to Improve Multi OIT OutcomesTreatment